Nanopharm Limited
- Active
- Large
- Holding
- 23 years
- 59 employees
- £3,216,747 (assets)
- £7,486,864 (revenue)
- Regular importer
- Regular exporter
- Real address
- 3 directors
- 1 owner
Two conditions of three:
1.Turnover > £36 million
2.Balance sheet total > £18 million
3.Average number of employees > 250
The directors list was changed 4 days ago, a good sign to sell them something.
Field of Operation
Website
Phones
Summary
Nanopharm Ltd, based in Leeds, UK, is a sizable company operating as a holding entity with an active status. Established 23 years ago in 2002, the company employs 59 people and boasts assets of £3,216,747, generating a yearly revenue of £7,486,864. With a real address and four directors, including Hall Christopher Maxwell, Pearson Douglas John, Rowe-joseph Gwenaelle, and Brouet Guillaume, it’s a well-structured organization. The company is owned by Aptargroup Uk Holdings Ltd.
Nanopharm specializes in providing highly specialized OINDP (Oral Inhalation Nasal Drug Product) development and analytical services, accelerating the development of drug-device combination products. Its website highlights expertise in nasal and inhaled drug delivery, catering to innovator, generic, and lifecycle management applications. They offer services ranging from preformulation and preclinical formulation to clinical development and regulatory consultancy, with a focus on unique insilico modeling platforms. They even research low GWP propellant inhalers, aiming for more sustainable drug products.
Financially, Nanopharm presents a mixed picture. While turnover increased by 28%, reaching £7.5 million, current assets declined by 20% to £3.2 million. Net assets decreased by 11% to £5 million. Bank borrowings increased significantly, jumping 93% to £460,000, while cash reserves plummeted 92% to £54,000. Creditors, however, decreased by 140%, suggesting improved management of short-term liabilities. The company's size—meeting two of three criteria for a large company—indicates a solid foundation, but the decrease in cash and increase in borrowings suggests it's burning through money. The lack of a mentioned auditor (likely exempt due to its size) means the figures are unaudited. The company’s significant investment in research and development, as evidenced by the increase in amortization expense, may be a factor in its current financial position.
Registered in England/Wales under the registration number 04371441, with a registered address at LS27 0LL, England, Leeds, 5 Bruntcliffe Avenue, Morley.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Corporate
- 6 years
- 75%+
-
Resident of United Kingdom
Managers
-
Individual
- 6 years
-
Resident of United Kingdom
-
Individual
- 6 years
-
Resident of France
-
Individual
- 6 years
-
Resident of France
Last reports
The latest confirmation statement submitted seven months ago.
Last news
-
Termination of appointment of Christopher Maxwell Hall as a director on 2025-07-21Download 1 page pdf report
-
Confirmation statement made on 2024-12-16 with no updatesDownload 3 pages pdf report
-
Full accounts made up to 2023-12-31Download 25 pages pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
Exporter profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last exported products
Click on items to see detailed UK statistics on HS code, including companies list.
FAQ about Nanopharm Limited
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!